Skip to main content
RADX logo
RADX
(NASDAQ)
Radiopharm Theranostics Limited
$4.40-- (--)
Loading... - Market loading

Radiopharm Theranostics (RADX) Stock Price & Financial Analysis

Radiopharm Theranostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.16 - $4.40
52-Week High$16.25
52-Week Low$3.50
Open$4.19
Volume23.97K
Average Volume (3M)23.97K
Market Cap30.59M
Shares Outstanding6.95M
Price to Sales (P/S)12.02
Price to Book (P/B)0.98
EV/EBITDA-0.38
Revenue (TTM)2.50M
Net Income (TTM)-26.43M
EPS (TTM)$-3.80
Profit Margin-1055.27%
Operating Margin-953.39%
Return on Equity (ROE)-85.60%
50-Day MA$4.84
200-Day MA$5.16
52-Week Change-7.69%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Radiopharm Theranostics

What is the current stock price for RADX?

As of the latest trading session, RADX stock trades at $4.40. The 52-week range is $3.50–$16.25, with a day range of $4.16–$4.40.

What is the P/E ratio for RADX?

The P/E ratio (Price-to-Earnings) for RADX is shown in the Key Statistics section. This valuation metric helps compare Radiopharm Theranostics Limited to industry peers.

Does RADX pay dividends?

Radiopharm Theranostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RADX?

Analyst ratings and recommendations for RADX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of RADX?

Radiopharm Theranostics's market capitalization is $30.6M, classifying it as a micro-cap company. Radiopharm Theranostics operates in the Healthcare sector within the Biotechnology industry.